Boehringer Ingelheim announced plans to lay off part of its sales team due to disappointing U.S. sales of its biosimilar version of AbbVie’s Humira, a popular arthritis treatment. The German pharmaceutical company intends to transition to a hybrid sales model by...
IceCure Medical (ICCM), renowned for its innovative cryoablation technology, has announced a noteworthy 26% surge in revenues stemming from sales of its ProSense systems and disposables for the fiscal year concluding on December 31, 2023. Although experiencing a...
UBS has tapped into the expertise of three seasoned bankers to spearhead its equity capital markets (ECM) division in the U.S., aiming to bolster its operations following the challenges posed by its acquisition of Credit Suisse last year. Gregor Feige and Brad Miller...
Manufacturing Data Sparks Rate-Cut Concerns: Investors Eye Fed’s Next Move Monday’s dose of good news in manufacturing was met with cautious glances from investors, as concerns over the Federal Reserve’s rate-cut plans loomed large. With pivotal...
ARK Investment Management’s Monday Moves: Tesla Tops Purchases, Twilio Sells Lead In the ever-evolving landscape of exchange-traded funds (ETFs), Cathie Wood’s ARK Investment Management remains a focal point with its daily transactions. On April 1st, 2024,...
Nippon Steel is determined to move forward with its proposed acquisition of U.S. Steel, emphasizing its longstanding presence in the United States, according to the company’s new president. The Japanese firm has reached an agreement to purchase U.S. Steel for...
